Frontlight ResearchEarly access
Trial site
Qingdao
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy3 trials
- Metastatic breast cancer3 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Gastric and oesophageal cancer1 trial
- High blood pressure1 trial
- Migraine1 trial
- Myasthenia gravis1 trial
- Stroke1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Lead sponsor
- Novartis Pharmaceuticals11 trials
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting
Active, not recruiting
Closed trials
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026